{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T11:56:14Z","timestamp":1774612574748,"version":"3.50.1"},"reference-count":38,"publisher":"American Society for Microbiology","issue":"12","license":[{"start":{"date-parts":[[2002,12,1]],"date-time":"2002-12-01T00:00:00Z","timestamp":1038700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2002,12]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            Cefpodoxime is one of five antimicrobial agents recommended by the National Committee for Clinical Laboratory Standards for screening isolates of\n            <jats:italic>Klebsiella<\/jats:italic>\n            spp. and\n            <jats:italic>Escherichia coli<\/jats:italic>\n            for extended-spectrum \u03b2-lactamase (ESBL) production. In a prior study, we noted that among 131\n            <jats:italic>E. coli<\/jats:italic>\n            isolates for which the MIC of at least one extended-spectrum cephalosporin (ESC) or aztreonam was \u22652 \u03bcg\/ml (suggesting the presence of ESBL production), there were 59 isolates (45.0%) for which the MIC of cefpodoxime was 2 to 4 \u03bcg\/ml (i.e., a positive ESBL screening test), but the MICs of ceftazidime, cefotaxime, and ceftriaxone were \u22641 \u03bcg\/ml (below the ESBL screening breakpoint). Thus, the results appeared to be false-positive ESBL screening tests. These 59 isolates were divided into five phenotypic groups based on the susceptibility patterns of the organisms to a variety of \u03b2-lactam agents and further characterized. The first group (32 isolates) all produced a TEM-1 \u03b2-lactamase, and changes in the major outer membrane proteins were detected in representative strains. The second group (18 isolates) lacked\n            <jats:italic>bla<\/jats:italic>\n            <jats:sub>TEM<\/jats:sub>\n            but showed a number of porin changes; some also showed a modest elevation in production of the AmpC chromosomal \u03b2-lactamase. In the third phenotypic group (seven isolates) all expressed an OXA-30 \u03b2-lactamase. Some also harbored altered porins. The two remaining phenotypes each had a distinct pattern of porin changes with or without \u03b2-lactamase production. These data indicate that several factors are associated with decreased susceptibility to cefpodoxime in\n            <jats:italic>E. coli<\/jats:italic>\n            , but none of the mechanisms are related to ESBL production. Current screening methods produced false-positive ESBL results for these isolates. Such isolates should not be classified as containing ESBLs, nor should interpretations of ESCs or aztreonam susceptibility be changed to resistant on test reports for these isolates.\n          <\/jats:p>","DOI":"10.1128\/aac.46.12.3829-3836.2002","type":"journal-article","created":{"date-parts":[[2002,11,15]],"date-time":"2002-11-15T20:02:26Z","timestamp":1037390546000},"page":"3829-3836","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":68,"title":["Mechanisms of Decreased Susceptibility to Cefpodoxime in\n            <i>Escherichia coli<\/i>"],"prefix":"10.1128","volume":"46","author":[{"given":"Antonio","family":"Oliver","sequence":"first","affiliation":[{"name":"Department of Microbiology, Ramon y Cajal Hospital, Madrid, Spain"},{"name":"Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda M.","family":"Weigel","sequence":"additional","affiliation":[{"name":"Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Kamile","family":"Rasheed","sequence":"additional","affiliation":[{"name":"Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"John E.","family":"McGowan","sequence":"additional","affiliation":[{"name":"Rollins School of Public Health, Emory University, Atlanta, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patti","family":"Raney","sequence":"additional","affiliation":[{"name":"Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fred C.","family":"Tenover","sequence":"additional","affiliation":[{"name":"Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","first-page":"3383","volume":"133","year":"1987","unstructured":"Aggeler, R., R. Then, and R. Ghosh. 1987. Reduced expression of outer-membrane proteins in \u03b2-lactam-resistant mutants of Enterobacter cloacae. J. Gen. Microbiol.133:3383-3392.","journal-title":"J. Gen. Microbiol."},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.1.210-212.2000"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.6.1211"},{"key":"e_1_3_2_5_2","first-page":"459","volume":"173","year":"1999","unstructured":"Caroff, N., E. Espaze, I. Berard, H. Richet, and A. Reynaud. 1999. Mutations in the ampC promoter of Escherichia coli isolates resistant to oxyminocephalosporins without extended spectrum \u03b2-lactamase production. FEMS Microbiology Lett.173:459-465.","journal-title":"FEMS Microbiology Lett."},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/45.6.783"},{"key":"e_1_3_2_7_2","first-page":"1167","volume":"48","year":"2000","unstructured":"Centers for Disease Control and Prevention. 2000. Laboratory capacity to detect antimicrobial resistance, 1998. Morb. Mortal. Wkly. Rep.48:1167-1171.","journal-title":"Morb. Mortal. Wkly. Rep."},{"key":"e_1_3_2_8_2","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1093\/nar\/12.7.3219","volume":"12","year":"1984","unstructured":"Chen, S. T., and R. C. Clowes. 1984. Two improved promoter sequences for the beta-lactamase expression arising from a single base-pair substitution. Nucleic Acids Res.12:3219-3234.","journal-title":"Nucleic Acids Res."},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-2836(81)90364-8"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.20.4.549"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.43.4.937"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/290221a0"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1982.tb01263.x"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.10.2709-2714.2000"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.8.4.557"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.9.2534-2536.2000"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1099\/00221287-88-1-169"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.5.1387-1390.2000"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/156.5.751"},{"key":"e_1_3_2_20_2","unstructured":"Murray P. R. E. J. Baron M. A. Pfaller F. C. Tenover and R. H. Yolken (ed.). 1999. Manual of clinical microbiology 7th ed. American Society for Microbiology. Washington D.C."},{"key":"e_1_3_2_21_2","unstructured":"National Committee for Clinical Laboratory Standards. 2000. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. NCCLS approved standard M7-A5. National Committee for Clinical Laboratory Standards Wayne Pa."},{"key":"e_1_3_2_22_2","unstructured":"National Committee for Clinical Laboratory Standards. 2002. Performance standards for antimicrobial susceptibility testing. NCCLS approved standard M100-S12. National Committee for Clinical Laboratory Standards Wayne Pa."},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.43.4.957"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2958.1987.tb00523.x"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.43.4.862"},{"key":"e_1_3_2_26_2","doi-asserted-by":"crossref","first-page":"7556","DOI":"10.1073\/pnas.80.24.7556","volume":"80","year":"1983","unstructured":"Olson, O., S. Bergstrom, F. P. Lindberg, and S. Normak. 1983. AmpC \u03b2-lactamase hyperproduction in Escherichia coli: natural ampicillin resistance generated by horizontal chromosomal DNA transfer from Shigella. Proc. Natl. Acad. Sci. USA80:7556-7560.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.84.21.7378"},{"key":"e_1_3_2_28_2","first-page":"295","volume":"68","year":"1990","unstructured":"Ozawa, Y., S. Mizushima, and T. Mizuno. 1990. Osmoregulatory expression of the ompC gene in Escherichia coli K-12; IS1 insertion in the upstream regulatory region results in constitutive activation of the promoter. FEMS Microbiol. Lett.68:295-300.","journal-title":"FEMS Microbiol. Lett."},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.3.647"},{"key":"e_1_3_2_30_2","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1699-0463.1996.tb04908.x","volume":"104","year":"1996","unstructured":"Schumacher, H., U. Skibsted, R. Skov, and J. Scheibel. 1996. Cefuroxime resistance in Escherichia coli.APMIS104:531-538.","journal-title":"APMIS"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1128\/jb.177.3.530-535.1995"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.8.2034-2038.2000"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(85)90442-7"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/0378-1119(86)90117-4"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.11.2478"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.39.8.2864-2872.2001"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.33.9.2233-2239.1995"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.38.3.494"},{"key":"e_1_3_2_39_2","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/BF00428737","volume":"181","year":"1981","unstructured":"Yamamoto, T., M. Tanaka, R. Baba, and S. Yamagishi. 1981. Physical and functional mapping of Tn2603, a transposon encoding ampicillin, streptomycin, sulfonamide, and mercury resistance. Mol. Gen. Genet.181:464-469.","journal-title":"Mol. Gen. Genet."}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.46.12.3829-3836.2002","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.46.12.3829-3836.2002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T17:35:32Z","timestamp":1645464932000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.46.12.3829-3836.2002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,12]]},"references-count":38,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2002,12]]}},"alternative-id":["10.1128\/AAC.46.12.3829-3836.2002"],"URL":"https:\/\/doi.org\/10.1128\/aac.46.12.3829-3836.2002","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,12]]},"assertion":[{"value":"2002-04-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2002-08-21","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2002-12-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}